Literature DB >> 15242675

Warfarin and the vitamin K-dependent gamma-carboxylation system.

Reidar Wallin1, Susan M Hutson.   

Abstract

Insight into the molecular basis for genetic warfarin resistance has recently been accomplished by the identification of an 18-kDa protein of the endoplasmic reticulum that is targeted by the drug. When expressed in eukaryotic and insect cells, the protein reduces vitamin K1 2,3-epoxide in a warfarin-sensitive reaction. This finding strongly suggests that the protein is part of the vitamin K cycle, which is essential for the production of vitamin K-dependent proteins. Identification of the 18-kDa protein has aided the understanding of the vitamin K-dependent gamma-carboxylation system at the molecular level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242675     DOI: 10.1016/j.molmed.2004.05.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  27 in total

1.  siRNA silencing of calumenin enhances functional factor IX production.

Authors:  Nadeem Wajih; Susan M Hutson; Reidar Wallin
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

2.  Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection.

Authors:  Nadeem Wajih; John Owen; Reidar Wallin
Journal:  Thromb Res       Date:  2008-01-03       Impact factor: 3.944

3.  Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses.

Authors:  James K Burmester; Richard L Berg; Ingrid Glurich; Steven H Yale; John R Schmelzer; Michael D Caldwell
Journal:  Clin Med Res       Date:  2011-05-11

4.  An ELISA-based method to quantify osteocalcin carboxylation in mice.

Authors:  Mathieu Ferron; Jianwen Wei; Tatsuya Yoshizawa; Patricia Ducy; Gerard Karsenty
Journal:  Biochem Biophys Res Commun       Date:  2010-06-04       Impact factor: 3.575

5.  A hetero-dimer model for concerted action of vitamin K carboxylase and vitamin K reductase in vitamin K cycle.

Authors:  Sangwook Wu; Shubin Liu; Charles H Davis; Darrel W Stafford; John D Kulman; Lee G Pedersen
Journal:  J Theor Biol       Date:  2011-03-29       Impact factor: 2.691

6.  Improved activity and expression of recombinant human factor IX by propeptide engineering.

Authors:  Jafar Vatandoost; Mettine H A Bos
Journal:  Daru       Date:  2019-10-21       Impact factor: 3.117

7.  A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats.

Authors:  Michael H Kohn; Roger E Price; Hans-Joachim Pelz
Journal:  Artery Res       Date:  2008-11       Impact factor: 0.597

8.  Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification.

Authors:  Reidar Wallin; Leon Schurgers; Nadeem Wajih
Journal:  Thromb Res       Date:  2008-01-30       Impact factor: 3.944

9.  Vitamin K-dependent gamma-glutamylcarboxylase in Atlantic salmon (Salmo salar L.).

Authors:  Christel Krossøy; Erik-Jan Lock; Robin Ørnsrud
Journal:  Fish Physiol Biochem       Date:  2009-08-15       Impact factor: 2.794

10.  Coumatetralyl resistance of Rattus tanezumi infesting oil palm plantations in Indonesia.

Authors:  J Andru; J F Cosson; J P Caliman; E Benoit
Journal:  Ecotoxicology       Date:  2012-12-21       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.